Serotonin 2C receptor agonists improve type 2 diabetes via melanocortin-4 receptor signaling pathways
journal contribution
posted on 2023-06-07, 17:51authored byLigang Zhou, Gregory M Sutton, Justin J Rochford, Robert K Semple, Daniel D Lam, Laura J Oksanen, Zoe D Thornton-Jones, Pete CliftonPete Clifton, Chen-Yu Yueh, Mark L Evans, Rory J McCrimmon, Joel K Elmquist, Andrew A Butler, Lora K Heisler